{"name":"Haemonetics Corporation","slug":"haemonetics-corporation","ticker":"","exchange":"","domain":"haemoneticscorporation.com","description":"Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNaTFISUNGaFVCMHFiTFpTQWNaNnNkRDJBeERlbndBeURoSmhMQkRQQ3ZrTFNrNy0yUndXMTdQb1hLUjR3Y3llVnRweWJLZllKd1lWOWlYNHRGRGNrX1lDTEV6eGV2czlWWUZBOTVRbmUtVlc5SDRqTUw4aWpCaGNneXVSOWxxNXNhZ2g0Z05OLUM4dE42ZVBYWnFnaTdtajgzZ3BfcnFRSTdVaFRwb3M2QjhjWGNMUkZGRUQ2TkgyV05seFZpaEdEVWQyZjJoZXZHOTNORDZQZHdxWk9GOUZUNA?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Haemonetics Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo","headline":"Haemonetics Corp. Experiences Revision in Stock Evaluation Amid Market Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPM3Fkemx4N1V4SkpVazZvejFJajFxY3ljX1Rxb0YwdDQ4WmI0MGp0aEoyN2czRnlVM3Q0MXhZckM0dlk4V3d0THZ6Y3ktMDhpLWhoNWtrRXlmeXpYUnl6a1laOFlEY1F3b2kzcnlWR3hpcXMzRHp2UUhMVi1FenpfM2pTOWhjbzRTQ0xwRE1sdnBfQnROMUZsV2ZCQ2c4ZmlmODJxZHBEdk0wb1h5VDFTOWItdlFuT1czSkc2a2ZRSi1sNHpE?oc=5","date":"2026-03-14","type":"pipeline","source":"AD HOC NEWS","summary":"Haemonetics Corp Stock (ISIN: US4041191090) Expands Hospital Portfolio Amid Valuation Discount and A - AD HOC NEWS","headline":"Haemonetics Corp Stock (ISIN: US4041191090) Expands Hospital Portfolio Amid Valuation Discount and A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNa0x5aGdydE1qcDU3Vmg5bkE5UGJ1Nkt3OHU0eS1rNjdYWFRVa01TTWpyLUNPZ0h6N284RjZkU1BqWHlmQjZZM1QzLXQ0UGVoOVpGUzRuWmpaWkhZNGZpZGI2MVVRcmkwdlJRdHFkeWlBa3RQRWR2TU8zZ01ocjdKMVRQWEVYY1dZNFBnRl9uNTBLb2pqejVoQW13cGt2b05fTFhKdjV3OGF5X05MSUJwTGFGSlVlRHRxV0drUEdKdGliVjZkVi1tNXJKQS1uN3pIRTdkbw?oc=5","date":"2026-03-13","type":"pipeline","source":"Markets Mojo","summary":"Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo","headline":"Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNdHFMRS1FU09kU194akpYMjRRaE5RZ1NDOXpGSnpvNE03WTNJdjVZTjBjVmo4enpDcFZ1LW85YlFDTV9NQ29SRzRZZ2dYLXBYSGlvYkRrWWxvRkFLV29KY3MyWm02SVQ0NHJtU2hCb1A3VGdqdEVVSkxCNFV1SDVQUnV1MHAzY3UtYnppWF9sSFA2bGJVMjRGQ2d6bG9HdzE0MTljU2pJcHZOaVZIbWU4T2t2ZVA3Y2syamVzTjlySFlnRTQ?oc=5","date":"2026-02-25","type":"pipeline","source":"PR Newswire","summary":"Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG - PR Newswire","headline":"Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxQa09OV0kwMWljb1F2MFNHb3picDlIRjMxcDV0MW5nc1VIYXB6SnduQ0pJSUtaMEtiQ3J2X05jWks2V2M1cEt0QU12NlRUQlBycnRLdl82YXluaE1OZVlBcFQ2Y0Fob2JOR1BEbHhVbWxNblBSQ2FKZUpSU2hXbllZVlUwUDk2U29OeTdaS0NKTFFRaWR1SHlKYXltUWFydEdPLW4tTEtTbHNRXzNrNVBDNi16amdmYUliUEdGaWJ0bms3cjAyWUdiemtSc0F0a2x6cmRheHkzaHYtckFteVFleDR3NkZlemdpc0pvdlZWSlBHTk41bFFkVTRudmlic1FkaXl3?oc=5","date":"2026-02-05","type":"earnings","source":"PR Newswire","summary":"Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website - PR Newswire","headline":"Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1jMGxhSDNlWC1yVWNEc09DUWhHVWRiX1dqeTZraTdxVFBqd21ndHowQjQ4QWVHN1A2WnkzS0NfU1l2ZjVMeHRIOGpXNkU1SUk3UG01X2VMaUlaa3lVZFp5Tzg0c0FTOGhPU1E?oc=5","date":"2026-01-14","type":"pipeline","source":"BUCKSCO.Today","summary":"New Hope’s Orchestra BioMed Set to Receive $21M from Vivasure Sale - BUCKSCO.Today","headline":"New Hope’s Orchestra BioMed Set to Receive $21M from Vivasure Sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxQQzZ4azJzRHpCOUhIeFFrZVlNS0VxMHZUbWtZWTMyZHdNZ2RIUDM2ak04c0UtWE9lYWFDM0tseFpveVp2UHduejV2WjMyYTVWbTRoRlB1YlhLaDltd3lnNkE5TW9tQk12SmozYW9oT2stZjFyNW1lN3AwelR1LWpqb25kM0xBbUZJZENXRnJiaTRQZUpnN2N3aFJHWXZ2M0Nndm9rM3BZLWU0eUp2Tmc1OW1yNDVKU3N6cUJFTmlPcDdHQzJ2c0pKXzc3eE1GVU9XNWFkd0c2ZFVtdkZ2UGdqeTNNZWo3a1JQMmhtcGhKNmI4X3FJQ3ZmZGctMWJoc2Y5NUhHbA?oc=5","date":"2025-11-06","type":"earnings","source":"PR Newswire","summary":"Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website - PR Newswire","headline":"Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOWnhnanVRMzgxQ3M0WEZnX3pOU0E2YjhPdE9haUZOQjd6SzlENXV0aFA4Y3l1MkdMeEtNQ1FkSXBCLU54aTdqdE9fRUprOGs5V0FNd2VnNzdPdVUzelFYWm05MTIzWWRhYlpnMUMzS2JhNTcwSnlqeTdhdnAzMGJ5Mg?oc=5","date":"2025-11-06","type":"earnings","source":"StocksToTrade","summary":"Haemonetics Reveals Fiscal Year 2026 Earnings Date Amid New Price Target Shift - StocksToTrade","headline":"Haemonetics Reveals Fiscal Year 2026 Earnings Date Amid New Price Target Shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBSYm1hUWdXSkdIQTNvWFJBZVZiQVdhdlltMlJUUVRSOVlZVnVXY2FkWFhXa0hsMl9HeWF1VGY1NUh2X0tpdDI1cjIxVXlwbWIyN0lwQXRRYlpCeWd1VnFpVURDY0wxUU0?oc=5","date":"2025-05-29","type":"pipeline","source":"Straits Research","summary":"Blood Products Market Size, Global Trends, Share And Growth Forecast to 2033 - Straits Research","headline":"Blood Products Market Size, Global Trends, Share And Growth Forecast to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSW50Wm5DUllkSmx5cGprNnlpbVpIVzhXbjRoRnVDaWNRdFF6bklILXpubW9SY0VPZk5YdEtGakpjSy1oZVJHSEMzQUdhdG1XNW5ITFN2QVM4bjQ3bVgtQ1ZTMzEtWXRRWWRmSlhjNXptY09GblI1NEJaY1Q3T0lKeFl0c1VVbVdPejZORGdsNTgwOVBJN21SOUdFdGN2TjZOb0JwMTRLUDlrZw?oc=5","date":"2025-03-03","type":"pipeline","source":"PR Newswire","summary":"Haemonetics Announces Executive Leadership Updates - PR Newswire","headline":"Haemonetics Announces Executive Leadership Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNUlrNS1yYlNDLXpNemxxT2g0T3hGV3dPQkJuUTBIYXUyejVtUDRCV053RHA3cVhlbHhMdXdRZS10eDRhZlJOVHNMSVlQdTlHemxSQUlkUFlqbTJPY3lmMlY4X2g4eTJwTzNwZGlGYkwxUHFZdUNwVXdjZEpRZzhfRjZ6bHduZmpObXo2dXVJaTBubkM2XzlFaEpnbk4xcmF4RzcxcjhMaFc0TkdpWUJjZG03Y1loYjhYMzJz?oc=5","date":"2024-04-01","type":"pipeline","source":"PR Newswire","summary":"Haemonetics Corporation Completes Acquisition of Attune Medical - PR Newswire","headline":"Haemonetics Corporation Completes Acquisition of Attune Medical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQX1M0RUpmZ1VDTXBIZjRGUFZJdzVoSUZxTlFleEtNU1VVX0tLUlZLMGIxaFhFVUhNSTdfV3VOMTZjRTQ2azdEYkpmN2RpUzN1WkhLZzJzQll6dllScWNiTnN2cFpvbkt4TGV0bGYtMVh1UTRVdEhqSjZMQ3ZVeEpGeWxVOUtuNEJKSzktZEJsNno2QWkyYmZBb3NVNkNabkJHWllSWEZqa05uVmZ3dTlxc3VlT2NFTmxBZC1xV3RsZGNRQQ?oc=5","date":"2024-03-05","type":"deal","source":"PR Newswire","summary":"Haemonetics Announces Definitive Agreement to Acquire Attune Medical - PR Newswire","headline":"Haemonetics Announces Definitive Agreement to Acquire Attune Medical","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}